Skip to main content
Top
Published in: Rheumatology International 4/2017

Open Access 01-04-2017 | Validation Studies

Development of an activity disease score in patients with uveitis (UVEDAI)

Authors: Esperanza Pato, Mª Auxiliadora Martin-Martinez, Adela Castelló, Rosalía Méndez-Fernandez, Santiago Muñoz-Fernández, Miguel Cordero-Coma, Lucia Martinez-Costa, Elia Valls, Miguel Reyes, Félix Francisco, Mar Esteban, Alex Fonollosa, Fernando Sanchez-Alonso, Cruz Fernández-Espartero, Teresa Diaz-Valle, José Miguel Carrasco, Emma Beltran-Catalán, Marisa Hernández-Garfella, María Victoria Hernández, Laura Pelegrin, Ricardo Blanco, David Diaz-Valle

Published in: Rheumatology International | Issue 4/2017

Login to get access

Abstract

To develop a disease activity index for patients with uveitis (UVEDAI) encompassing the relevant domains of disease activity considered important among experts in this field. The steps for designing UVEDAI were: (a) Defining the construct and establishing the domains through a formal judgment of experts, (b) A two-round Delphi study with a panel of 15 experts to determine the relevant items, (c) Selection of items: A logistic regression model was developed that set ocular inflammatory activity as the dependent variable. The construct “uveitis inflammatory activity” was defined as any intraocular inflammation that included external structures (cornea) in addition to uvea. Seven domains and 15 items were identified: best-corrected visual acuity, inflammation of the anterior chamber (anterior chamber cells, hypopyon, the presence of fibrin, active posterior keratic precipitates and iris nodules), intraocular pressure, inflammation of the vitreous cavity (vitreous haze, snowballs and snowbanks), central macular edema, inflammation of the posterior pole (the presence and number of choroidal/retinal lesions, vascular inflammation and papillitis), and global assessment from both (patient and physician). From all the variables studied in the multivariate model, anterior chamber cell grade, vitreous haze, central macular edema, inflammatory vessel sheathing, papillitis, choroidal/retinal lesions and patient evaluation were included in UVEDAI. UVEDAI is an index designed to assess the global ocular inflammatory activity in patients with uveitis. It might prove worthwhile to motorize the activity of this extraarticular manifestation of some rheumatic diseases.
Appendix
Available only for authorised users
Literature
2.
go back to reference Rothova A, Suttorp-van Schulten MS, Frits Treffers W et al (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332–336CrossRefPubMedPubMedCentral Rothova A, Suttorp-van Schulten MS, Frits Treffers W et al (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332–336CrossRefPubMedPubMedCentral
3.
go back to reference Bodaghi B, Cassoux N, Wechsler B et al (2001) Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 80:263–270CrossRef Bodaghi B, Cassoux N, Wechsler B et al (2001) Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 80:263–270CrossRef
4.
go back to reference Jabs DA, Nussenblatt RB, Rosenbaum JT et al (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516CrossRefPubMed Jabs DA, Nussenblatt RB, Rosenbaum JT et al (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516CrossRefPubMed
5.
go back to reference Trusko B, Thorne J, Jabs D et al (2013) The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med 52:259–265. doi:10.3414/ME12-01-0063 CrossRefPubMed Trusko B, Thorne J, Jabs D et al (2013) The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med 52:259–265. doi:10.​3414/​ME12-01-0063 CrossRefPubMed
6.
go back to reference Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234–235CrossRefPubMed Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234–235CrossRefPubMed
10.
go back to reference van der Heijde DM, van‘t Hof MA, van Riel PL et al (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920CrossRefPubMedPubMedCentral van der Heijde DM, van‘t Hof MA, van Riel PL et al (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920CrossRefPubMedPubMedCentral
11.
go back to reference van der Heijde DM, van ‘t Hof MA, van Riel PL et al (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20:579–581PubMed van der Heijde DM, van ‘t Hof MA, van Riel PL et al (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20:579–581PubMed
15.
16.
go back to reference Whitcup SM (2004) Examination of the patient with uveitis. In: Mosby (ed) Uveitis fundamentals and clinical practice. Elsevier, St Louis, pp 54–65 Whitcup SM (2004) Examination of the patient with uveitis. In: Mosby (ed) Uveitis fundamentals and clinical practice. Elsevier, St Louis, pp 54–65
17.
go back to reference Nussenblatt RB, Palestine AG, Chan CC et al (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92:467–471CrossRefPubMed Nussenblatt RB, Palestine AG, Chan CC et al (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92:467–471CrossRefPubMed
19.
go back to reference Peduzzi P, Concato J, Feinstein AR et al (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503–1510CrossRefPubMed Peduzzi P, Concato J, Feinstein AR et al (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503–1510CrossRefPubMed
20.
go back to reference Concato J, Peduzzi P, Holford TR et al (1995) Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol 48:1495–1501CrossRefPubMed Concato J, Peduzzi P, Holford TR et al (1995) Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol 48:1495–1501CrossRefPubMed
21.
go back to reference Peduzzi P, Concato J, Kemper E et al (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379CrossRefPubMed Peduzzi P, Concato J, Kemper E et al (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379CrossRefPubMed
22.
go back to reference Hajian-Tilaki K (2013) Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med 4:627–635 Hajian-Tilaki K (2013) Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med 4:627–635
23.
go back to reference Hanley JA (1989) Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29:307–335PubMed Hanley JA (1989) Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29:307–335PubMed
24.
go back to reference Linnet K (1987) Comparison of quantitative diagnostic tests: type I error, power, and sample size. Stat Med 6:147–158CrossRefPubMed Linnet K (1987) Comparison of quantitative diagnostic tests: type I error, power, and sample size. Stat Med 6:147–158CrossRefPubMed
25.
go back to reference Heiligenhaus A, Foeldvari I, Edelsten C et al (2012) Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res (Hoboken) 64:1365–1372. doi:10.1002/acr.2167 CrossRef Heiligenhaus A, Foeldvari I, Edelsten C et al (2012) Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res (Hoboken) 64:1365–1372. doi:10.​1002/​acr.​2167 CrossRef
30.
go back to reference Lardenoye CW, van Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113:1446–1449CrossRefPubMed Lardenoye CW, van Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113:1446–1449CrossRefPubMed
31.
go back to reference Iannetti L, Spinucci G, Abbouda A et al (2012) Spectral-domain optical coherence tomography in uveitic macular edema: morphological features and prognostic factors. Ophthalmologica 228:13–18. doi:10.1159/000337234 CrossRefPubMed Iannetti L, Spinucci G, Abbouda A et al (2012) Spectral-domain optical coherence tomography in uveitic macular edema: morphological features and prognostic factors. Ophthalmologica 228:13–18. doi:10.​1159/​000337234 CrossRefPubMed
35.
go back to reference Pacor ML, Biasi D, Lunardi C et al (1994) Cyclosporin in Behcet’s disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 13:224–227PubMed Pacor ML, Biasi D, Lunardi C et al (1994) Cyclosporin in Behcet’s disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 13:224–227PubMed
36.
go back to reference Miserocchi E, Baltatzis S, Ekong A et al (2002) Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience. Ophthalmology 109:137–142CrossRefPubMed Miserocchi E, Baltatzis S, Ekong A et al (2002) Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience. Ophthalmology 109:137–142CrossRefPubMed
37.
go back to reference Vianna RN, Ozdal PC, Deschenes J et al (2006) Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. Can J Ophthalmol 41:183–189CrossRefPubMed Vianna RN, Ozdal PC, Deschenes J et al (2006) Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. Can J Ophthalmol 41:183–189CrossRefPubMed
Metadata
Title
Development of an activity disease score in patients with uveitis (UVEDAI)
Authors
Esperanza Pato
Mª Auxiliadora Martin-Martinez
Adela Castelló
Rosalía Méndez-Fernandez
Santiago Muñoz-Fernández
Miguel Cordero-Coma
Lucia Martinez-Costa
Elia Valls
Miguel Reyes
Félix Francisco
Mar Esteban
Alex Fonollosa
Fernando Sanchez-Alonso
Cruz Fernández-Espartero
Teresa Diaz-Valle
José Miguel Carrasco
Emma Beltran-Catalán
Marisa Hernández-Garfella
María Victoria Hernández
Laura Pelegrin
Ricardo Blanco
David Diaz-Valle
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 4/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3593-1

Other articles of this Issue 4/2017

Rheumatology International 4/2017 Go to the issue